Hypoguard (Minneapolis, MN) has received FDA approval for the Advance Micro-Draw blood glucose system. This convenient system offers diabetics the option to use alternate site testing when checking their blood glucose levels. It gives patients the ability to draw a blood sample from their palm, in addition to traditional fingertip tests, offering a less painful way to measure blood glucose levels.
The Advance Micro-Draw system features biosensor technology and requires only a small blood sample. According to Hypoguard, its small sample size results in less painful, more comfortable testing.
Only two simple steps are required to use the device, which produces accurate test results in just 15 seconds. Advance Micro-Draw has a large display with easy-to-read digits for patients with visual impairments. The system also provides data management capabilities, including date and time, 250-test memory, and 14-to 30-day averaging. This product is covered by Medicare.
For more information, visit http://www.hypoguard.com.